Stay updated on Eptinezumab Efficacy in Refractory Migraine Clinical Trial
Sign up to get notified when there's something new on the Eptinezumab Efficacy in Refractory Migraine Clinical Trial page.

Latest updates to the Eptinezumab Efficacy in Refractory Migraine Clinical Trial page
- Check7 days agoChange DetectedRecord History now includes new sections and controls (Compare, Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and Study Status) and lists dated version entries. This change enhances the ability to review and compare how the study record has evolved over time by exposing key data sections in the history view.SummaryDifference21%

- Check14 days agoChange DetectedA new revision entry (v3.6.5) was added to the study history, replacing the previous revision (v3.6.4), reflecting an update to the page metadata.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe Record History page updated its site revision label from v3.6.3 to v3.6.4, indicating a platform version update included in the page. This reflects maintenance work rather than changes to the study record itself.SummaryDifference0.1%

- Check50 days agoChange DetectedThe Study Record History now shows a new revision entry v3.6.3, superseding the previous v3.6.2, indicating an update to the page data.SummaryDifference0.1%

- Check57 days agoChange DetectedThe record history now includes a new revision entry (v3.6.2) and removes the previous v3.6.0, updating the page's revision metadata.SummaryDifference0.1%

- Check71 days agoChange DetectedThe history now shows that recruitment for the study has ceased, indicating it is no longer enrolling participants. The record version has been updated to v3.6.0, replacing the previous v3.5.5 entry.SummaryDifference0.3%

Stay in the know with updates to Eptinezumab Efficacy in Refractory Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eptinezumab Efficacy in Refractory Migraine Clinical Trial page.